(Q37117994)

18 August 2017

1 reference

title

Fibromyalgia: harmonizing science with clinical practice considerations (English)

1 reference

18 August 2017

0 references

Robert M Bennett

3

0 references

author name string

Serge Perrot

series ordinal

1

1 reference

18 August 2017

Anthony H Dickenson

series ordinal

2

1 reference

18 August 2017

publication date

18 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

177-189

1 reference

Epidemiology of fibromyalgia

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

The prevalence and characteristics of fibromyalgia in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Central sensitization in fibromyalgia and other musculoskeletal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Symptoms, syndromes, and the value of psychiatric diagnostics in patients who have functional somatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Assessment of functional ability in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Evidence of involvement of central neural mechanisms in generating fibromyalgia pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Peripheral and central sensitization in fibromyalgia: pathogenetic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Family study of affective spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

The rational management of fibromyalgia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Psychological and behavioral approaches to pain management for patients with rheumatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Central Acute Pain Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Bad news from the brain: descending 5-HT pathways that control spinal pain processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Pains, gains, and midbrains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Voltage-gated calcium channels as targets for the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Neurophysiologic evidence for a central sensitization in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Fibromyalgia syndrome, idiopathic widespread persistent pain or syndrome of myalgic encephalomyelopathy (SME): what is its nature?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Evidence-based data on pain relief with antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Antidepressant treatment of fibromyalgia. A meta-analysis and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Treatment of fibromyalgia with antidepressants: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

A double-blind placebo controlled trial of fluoxetine in fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Management of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2008.00190.X

10.1111/J.1533-2500.2008.00190.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference